Refractory B-cell precursor acute lymphoblastic leukemia

Also known as: Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory / Precursor B-lymphoblastic lymphoma/leukemia refractory / Refractory B cell precursor Acute lymphoblastic leukemia / Refractory B-cell precursor Acute Lymphoblastic Anemia / Precursor B-lymphoblastic lymphoma refractory / Precursor B-lymphoblastic lymphoma NOS refractory

DrugDrug NameDrug Description
DB09052BlinatumomabAn antineoplastic antibody used to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
DB05889Inotuzumab ozogamicinAn antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL).
DB13881TisagenlecleucelA CAR T cell therapy for relapsed or refractory large B-cell lymphoma and diffuse large B-cell lymphoma.
DrugDrug NamePhaseStatusCount
DB13881Tisagenlecleucel2Unknown Status1